Hemma Rajendra provides “bedside-to-bedside” care and ensures that patients in an emergency evacuation get continuous medical ...
Takeda HAE global medical lead Irmgard Andresen stated ... We welcome the swift approval by the EMA on this additional subcutaneous administration option. “HAE patients 12 years and older ...
Missling confirmed that the company anticipates EMA feedback on blarcamesine’s Marketing Authorization Application by the end of 2025. He stated that the company is prepared for the review ...
The study found that just 20% of trials submitted to both the FDA and European Medicines Agency had matching evidence.